An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis-Reference-Cited by-同舟云学术

An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis

Published:2002-12 Issue:12 Volume:24 Page:2105-2122
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Weiss Karl,Vanjaka Anita

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Epidemiology of chronic airways disease;Woolcock;Chest,1989

2. COPD and Rehabilitation Committee of the Canadian Thoracic Society;Lacasse,1999

3. The role of antibiotics in the management of acute exacerbation of chronic bronchitis;Skudlarska;Mo Med,1992

4. Epidemiology and treatment of chronic bronchitis and its exacerbations;Ball;Chest,1995

5. Role of infection in chronic bronchitis;Tager;N Engl J Med,1975

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clarithromycin sustained-release tablet may be an improper therapy for the eradication of Helicobacter pylori;Therapeutic Advances in Gastroenterology;2024-01

2. Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin;Lung India;2018

3. Interventions for enhancing medication adherence;Cochrane Database of Systematic Reviews;2014-11-20

4. EVALUATION OF EFFICACY AND SAFETY OF GEMIFLOXACIN IN CHRONIC BRONCHITIS PATIENTS;International journal of pharmaceutical sciences and research;2014-05-01

5. Application of lactobionic acid and nonionic surfactants as solubilizing agents for parenteral formulation of clarithromycin;ADV PHARM BULL;2012